Pilot Growth Equity

Bizzabo Ltd. is a cloud-based event management platform that provides a comprehensive suite of tools designed to enhance the planning and execution of in-person, virtual, and hybrid events. Founded in 2011 and headquartered in Tel Aviv-Yafo, Israel, the company offers services such as registration and ticketing, event marketing, agenda management, networking applications, and data management tools. Bizzabo's platform is engineered to facilitate immersive experiences, enabling organizations to engage audiences effectively and achieve significant business outcomes while ensuring the privacy and security of attendee data. The company serves a diverse clientele, including corporations, marketing agencies, third-party planners, and associations. With a workforce of over 300 employees across offices in New York, Tel Aviv, Kyiv, London, and various remote locations, Bizzabo has established itself as a trusted partner for leading global brands in managing their events.

Tailwind is a prominent marketing platform tailored for small businesses, entrepreneurs, creators, and marketers. It provides tools that facilitate the planning, creation, execution, and optimization of marketing campaigns across various digital platforms, including email, Facebook, Instagram, and Pinterest. By integrating multiple standalone marketing tools into a unified system, Tailwind aims to empower small businesses to become effective omni-channel marketers, catering to their specific needs. Additionally, Tailwind offers a utility-first CSS framework designed to simplify content marketing, enabling users to enhance their marketing efforts and connect with a broader audience. Through its comprehensive suite of services, Tailwind is reshaping the marketing landscape for small businesses.

R4 Technologies is a company focused on enhancing cross-enterprise management through the application of artificial intelligence. Its business-as-a-service platform aims to democratize data science for business users, enabling them to access and utilize insights derived from various data sources across organizations. By employing artificial intelligence and machine learning, R4 Technologies helps businesses unlock growth opportunities that are often hidden within enterprise silos, systems, and processes. The platform provides yield management insights, allowing companies to make informed decisions more swiftly, thereby driving growth and efficiency.

Bizzabo Ltd. is a cloud-based event management platform that provides a comprehensive suite of tools designed to enhance the planning and execution of in-person, virtual, and hybrid events. Founded in 2011 and headquartered in Tel Aviv-Yafo, Israel, the company offers services such as registration and ticketing, event marketing, agenda management, networking applications, and data management tools. Bizzabo's platform is engineered to facilitate immersive experiences, enabling organizations to engage audiences effectively and achieve significant business outcomes while ensuring the privacy and security of attendee data. The company serves a diverse clientele, including corporations, marketing agencies, third-party planners, and associations. With a workforce of over 300 employees across offices in New York, Tel Aviv, Kyiv, London, and various remote locations, Bizzabo has established itself as a trusted partner for leading global brands in managing their events.

Counsyl is a health technology company specializing in DNA screening services for individuals and families. The company focuses on providing critical information that can significantly influence health outcomes, enabling proactive measures and informed decision-making. With a strong commitment to accessibility, Counsyl has screened over 500,000 patients and collaborated with more than 6,000 healthcare professionals through its accredited clinical laboratory. It employs sophisticated technology and custom robotic automation to analyze blood and saliva samples with precision and efficiency. The platform not only aids in family planning through its Family Prep Screen but also encompasses informed pregnancy and cancer screening. Recognized for its innovative approach, Counsyl has received accolades such as the Wall Street Journal’s Innovation Award for Medicine and has been listed among Scientific American's "Top 10 World Changing Ideas." The company combines the expertise of scientists, engineers, and clinical professionals to enhance communication between patients and healthcare providers regarding medical results.

Webgility, Inc. is a software company that specializes in accounting automation for e-commerce businesses, accountants, and NetSuite retailers. Founded in 2007 and based in Scottsdale, Arizona, the company offers a comprehensive solution that connects sales, accounting, inventory, and shipping data, streamlining operations and improving workflows. Its software enables users to automatically record orders, manage financial data, and forecast sales while providing insights into growth rates, inventory levels, and business metrics. Webgility's platform eliminates manual data entry, minimizes errors, and centralizes financial information, empowering small and medium-sized businesses to enhance their e-commerce capabilities and operational efficiency. The Modern Commerce Workspace™ specifically caters to businesses using QuickBooks, allowing them to expand their online presence and gain valuable insights for faster growth.

Metabiota, Inc. is a San Francisco-based company founded in 2008 that specializes in assessing and investigating infectious disease threats. The company employs pathogen discovery, disease detection, and threat characterization to provide data, analytics, and strategies aimed at reducing and preventing infectious disease outbreaks. Metabiota’s platform allows local authorities and organizations to prepare mitigation strategies and manage complex infectious disease risks effectively. By offering surveillance, recognition, and diagnosis of microbial threats, Metabiota plays a critical role in helping governments and corporations track and respond to global health challenges. Through its strategic global presence and partnerships, the company is dedicated to mitigating the impacts of epidemic threats.

Velocidi is a customer data platform based in New York, with an additional office in Porto, Portugal. The company provides a private CDP that is deployed within each client's own infrastructure, facilitating a solution that feels integrated and in-house. Velocidi's platform is designed for direct-to-consumer brands, allowing them to collect and unify first-party customer data from both online and offline sources. The platform employs machine learning to predict customer behavior and enables users to activate audience segments directly on advertising platforms. This approach ensures that clients maintain complete ownership and control of their data while measuring, reporting, and optimizing their marketing efforts in real-time, thereby supporting the creation of omnichannel and multi-device customer journeys.

Leveraging its trusted, Cloud-based, globally distributed platform, its patent-pending monitoring and mitigation technology, and its unparalleled expertise in cyberattack mitigation, Zenedge provides organizations an enterprise-class, managed white-glove cybersecurity service to help secure their web sites, web applications, and networks against vulnerabilities and Distributed Denial of Service (DDoS) attacks. Unlike other Web Application Security solutions in the market, Zenedge leverages patent-pending deep machine-learning capabilities to detect anomalies, dynamically alter security postures, and initiate auto-mitigation and automatic routing with minimal to zero human intervention. This allows the company to provide better cybersecurity and faster time to mitigation than traditional Cloud and on-premise cybersecurity vendors.

Perthera, Inc. is a biotechnology company based in McLean, Virginia, specializing in personalized medicine for cancer treatment. Established in 2011, the firm develops a precision cancer analysis platform that provides comprehensive molecular information about tumors. This technology equips oncologists with detailed insights and actionable therapy options tailored to each patient's unique molecular profile and medical history. Perthera's platform aims to enhance treatment efficacy by identifying precisely matched therapeutic options ranked by their likelihood of success. The company collaborates with Theralink Technologies to further its mission of improving patient outcomes through advanced precision medicine.

CB Insights is a market intelligence platform that specializes in predicting company health, investor performance, and technology trends. The platform analyzes millions of data points related to venture capital, startups, patents, partnerships, and market news, providing clients with comprehensive insights into privately held companies and investment opportunities. It serves a diverse clientele engaged in private equity, venture capital, corporate development, investment banking, corporate innovation, and consulting. By offering tools for deal sourcing, due diligence, and competitive intelligence, CB Insights aims to enhance the efficiency and effectiveness of its users in navigating the complex landscape of private company information.

Metabiota, Inc. is a San Francisco-based company founded in 2008 that specializes in assessing and investigating infectious disease threats. The company employs pathogen discovery, disease detection, and threat characterization to provide data, analytics, and strategies aimed at reducing and preventing infectious disease outbreaks. Metabiota’s platform allows local authorities and organizations to prepare mitigation strategies and manage complex infectious disease risks effectively. By offering surveillance, recognition, and diagnosis of microbial threats, Metabiota plays a critical role in helping governments and corporations track and respond to global health challenges. Through its strategic global presence and partnerships, the company is dedicated to mitigating the impacts of epidemic threats.

Metabiota, Inc. is a San Francisco-based company founded in 2008 that specializes in assessing and investigating infectious disease threats. The company employs pathogen discovery, disease detection, and threat characterization to provide data, analytics, and strategies aimed at reducing and preventing infectious disease outbreaks. Metabiota’s platform allows local authorities and organizations to prepare mitigation strategies and manage complex infectious disease risks effectively. By offering surveillance, recognition, and diagnosis of microbial threats, Metabiota plays a critical role in helping governments and corporations track and respond to global health challenges. Through its strategic global presence and partnerships, the company is dedicated to mitigating the impacts of epidemic threats.

Counsyl is a health technology company specializing in DNA screening services for individuals and families. The company focuses on providing critical information that can significantly influence health outcomes, enabling proactive measures and informed decision-making. With a strong commitment to accessibility, Counsyl has screened over 500,000 patients and collaborated with more than 6,000 healthcare professionals through its accredited clinical laboratory. It employs sophisticated technology and custom robotic automation to analyze blood and saliva samples with precision and efficiency. The platform not only aids in family planning through its Family Prep Screen but also encompasses informed pregnancy and cancer screening. Recognized for its innovative approach, Counsyl has received accolades such as the Wall Street Journal’s Innovation Award for Medicine and has been listed among Scientific American's "Top 10 World Changing Ideas." The company combines the expertise of scientists, engineers, and clinical professionals to enhance communication between patients and healthcare providers regarding medical results.